Picture of Rezolute logo

RZLT Rezolute Cashflow Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapMomentum Trap

Annual cashflow statement for Rezolute, fiscal year end - June 30th, USD millions except per share, conversion factor applied.

2019
June 30th
2020
June 30th
2021
June 30th
2022
June 30th
2023
June 30th
Period Length:12 M12 M12 M12 M12 M
Source:10-K10-K10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-30.4-20.3-20.9-41.1-51.8
Depreciation
Non-Cash Items6.743.642.571.776.25
Unusual Items
Other Non-Cash Items
Changes in Working Capital8.36-7.49-2.12-0.3421.02
Change in Prepaid Expenses
Change in Accounts Payable
Change in Accrued Expenses
Change in Payable / Accrued Expenses
Change in Other Liabilities
Cash from Operating Activities-15.3-24.2-20.4-39.6-44.5
Capital Expenditures-0.0470-0.153
Purchase of Fixed Assets
Other Investing Cash Flow Items0.2780-101
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Cash from Investing Activities0.2310-101
Financing Cash Flow Items25-1.5-4.47-20-0.759
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities2522.651.514911.6
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash9.93-1.6231.1109-134